Skip to main content

The Impact of Independent Chemotherapy Prescribing by Advanced Practice Providers on Patient Safety and Clinician Satisfaction.

Publication ,  Journal Article
LeStrange, N; Walton, A; Watson, JL; Sklarin, NT; Thompson, JA; Affronti, ML
Published in: Clinical journal of oncology nursing
July 2024

Literature on advanced practice providers (APPs) prescribing chemotherapy independently, without physician cosignature, is limited.This project assessed safety and provider satisfaction for an existing independent APP chemotherapy prescribing privilege at a National Cancer Institute-designated comprehensive cancer center.Rate of Reporting to Improve Safety and Quality events associated with APPs with independent chemotherapy prescribing privileges was compared to that of physicians during a three-year period. Satisfaction of APPs with independent chemotherapy prescribing privileges was evaluated.The odds of a reported event were higher for physicians than for APPs. APP survey responses were positive for readiness, confidence, and satisfaction with independent chemotherapy prescribing privilege.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clinical journal of oncology nursing

DOI

EISSN

1538-067X

ISSN

1092-1095

Publication Date

July 2024

Volume

28

Issue

4

Start / End Page

397 / 405

Related Subject Headings

  • United States
  • Surveys and Questionnaires
  • Patient Safety
  • Neoplasms
  • Middle Aged
  • Male
  • Humans
  • Female
  • Drug Prescriptions
  • Antineoplastic Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
LeStrange, N., Walton, A., Watson, J. L., Sklarin, N. T., Thompson, J. A., & Affronti, M. L. (2024). The Impact of Independent Chemotherapy Prescribing by Advanced Practice Providers on Patient Safety and Clinician Satisfaction. Clinical Journal of Oncology Nursing, 28(4), 397–405. https://doi.org/10.1188/24.cjon.397-405
LeStrange, Nicole, AnnMarie Walton, Joni L. Watson, Nancy T. Sklarin, Julie A. Thompson, and Mary Lou Affronti. “The Impact of Independent Chemotherapy Prescribing by Advanced Practice Providers on Patient Safety and Clinician Satisfaction.Clinical Journal of Oncology Nursing 28, no. 4 (July 2024): 397–405. https://doi.org/10.1188/24.cjon.397-405.
LeStrange N, Walton A, Watson JL, Sklarin NT, Thompson JA, Affronti ML. The Impact of Independent Chemotherapy Prescribing by Advanced Practice Providers on Patient Safety and Clinician Satisfaction. Clinical journal of oncology nursing. 2024 Jul;28(4):397–405.
LeStrange, Nicole, et al. “The Impact of Independent Chemotherapy Prescribing by Advanced Practice Providers on Patient Safety and Clinician Satisfaction.Clinical Journal of Oncology Nursing, vol. 28, no. 4, July 2024, pp. 397–405. Epmc, doi:10.1188/24.cjon.397-405.
LeStrange N, Walton A, Watson JL, Sklarin NT, Thompson JA, Affronti ML. The Impact of Independent Chemotherapy Prescribing by Advanced Practice Providers on Patient Safety and Clinician Satisfaction. Clinical journal of oncology nursing. 2024 Jul;28(4):397–405.

Published In

Clinical journal of oncology nursing

DOI

EISSN

1538-067X

ISSN

1092-1095

Publication Date

July 2024

Volume

28

Issue

4

Start / End Page

397 / 405

Related Subject Headings

  • United States
  • Surveys and Questionnaires
  • Patient Safety
  • Neoplasms
  • Middle Aged
  • Male
  • Humans
  • Female
  • Drug Prescriptions
  • Antineoplastic Agents